| Description: |
Background The hospital-led interventions yielding the best hepatitis C virus (HCV) testing and treatment uptake are poorly understood. Methods We searched Medline, Embase, and Cochrane databases for studies assessing outcomes of hospital-led interventions for HCV antibody or RNA testing uptake, linkage to care, or direct-acting antiviral commencement compared with usual care, a historical comparator, or control group. We systematically reviewed hospital-led interventions delivered in inpatient units, outpatient clinics, or emergency departments. Random-effects meta-analysis estimated pooled odds ratios [pORs] measuring associations between interventions and outcomes. Subgroup analyses explored outcomes by intervention type. Results A total of 7872 abstracts were screened with 23 studies included. Twelve studies (222 868 participants) reported antibody testing uptake, 5 (n = 4987) reported RNA testing uptake, 7 (n = 3185) reported linkage to care, and 4 (n = 1344) reported treatment commencement. Hospital-led interventions were associated with increased antibody testing uptake (pOR, 5.83 [95% confidence interval {CI}, 2.49–13.61]; I2 = 99.9%), RNA testing uptake (pOR, 10.65 [95% CI, 1.70–66.50]; I2 = 97.9%), and linkage to care (pOR, 1.75 [95% CI, 1.10–2.79]; I2 = 79.9%) when data were pooled and assessed against comparators. Automated opt-out testing (5 studies: pOR, 16.13 [95% CI, 3.35–77.66]), reflex RNA testing (4 studies: pOR, 25.04 [95% CI, 3.63–172.7]), and care coordination and financial incentives (4 studies: pOR, 2.73 [95% CI, 1.85–4.03]) showed the greatest increases in antibody and RNA testing uptake and linkage to care, respectively. No intervention increased uptake at all care cascade steps. Conclusions Automated antibody and reflex RNA testing increase HCV testing uptake in hospitals but have limited impact on linkage to treatment. Other interventions promoting linkage must be explored. |